Biotech companies such as Amyris, Evolva, Conagen, and Cambridge Glycoscience are now on the verge of trying to capture tiny slices of the $80bn global sweeteners market. Demand for sweeteners has been accelerating driven by the demand for natural sweeteners to replace aspartame and sucralose with consumers demanding clean labels.
According to Euromonitor International, future development in sweeteners will focus almost entirely on finding new natural sweeteners, which can follow the success of stevia that has experienced a 39% CAGR over the 2011-2015 period. There will also be further refinement of stevia, with the goal of providing a sweetener that enables 100% sugar replacement, tastes good and is natural. New manufacturing methods, such as fermentation, are expected to increase in prominence.
Author: Tecnon OrbiChem